Sleep Disorder Pill Available After DEA Clearance Removes Final Hurdle
Nov 12 (Reuters) - Takeda said on Thursday its narcolepsy pill, the first treatment to target the underlying cause of the rare sleep disorder, is now available in the US after a Drug Enforcement Administration decision removed the final regulatory hurdle …